Restricted Cash

12 Months Ended

Dec. 31, 2019

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]

Cash And Cash Equivalents Disclosure [Text Block]

Note 12 – Restricted Cash

The Company has restricted cash recorded in other assets related to proceeds from an inactive subsidiary of the Company which previously executed separate settlement and release agreements with two of its insurance carriers for an original total value of $35.0 million. The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. The proceeds of the settlement and release agreements have been deposited into interest bearing accounts which earned $0.2 million in both the years ended December 31, 2019 and 2018, offset by $0.8 million and $1.1 million of net payments during 2019 and 2018, respectively. Due to the restricted nature of the proceeds, a corresponding deferred credit was established in other non-current liabilities for an equal and offsetting amount, and will remain until the restrictions lapse or the funds are exhausted via payments of claims and costs of defense. See Notes 18, 22 and 26 of Notes to Consolidated Financial Statements.

The following table provides a reconciliation of cash, cash equivalents and restricted cash as December 31, 2019, 2018, 2017 and 2016:

	2019		2018		2017		2016
Cash and cash equivalents	$	123,524	$	104,147	$	89,879	$	88,818
Restricted cash included in other current assets		353		—		—		—
Restricted cash included in other assets		19,678		20,278		21,171		21,883
Cash, cash equivalents and restricted cash	$	143,555	$	124,425	$	111,050	$	110,701